Recently, Qingdao Anouve Biomedical Technology Co., Ltd. announced exciting news that two of its core independently developed products—the Disposable Cell-Free DNA Preservation Tube and the Disposable Cell-Free RNA Preservation Tube—have each officially obtained the Class II Medical Device Registration Certificate issued by the National Medical Products Administration (NMPA). The successful certification of both products marks the national authoritative recognition of the company's R&D and industrialization capabilities in core consumables for sample preprocessing in the in vitro diagnosis (IVD) field. It lays a solid compliance foundation for the products to enter clinical application and serve the global healthcare market, and is a high recognition of the company's product technology and quality, as well as a major breakthrough in the layout of its sample preprocessing product pipeline.

        As a critical step in molecular diagnosis, sample preprocessing directly determines the accuracy of test results, and the performance and compliant qualification of cell-free nucleic acid preservation tubes are important prerequisites for clinical application. Both certified products are independently developed by the company with complete independent intellectual property rights. They are tailored to actual clinical needs, applicable to the collection and preservation of blood samples for various molecular diagnosis scenarios such as tumor liquid biopsy and non-invasive prenatal screening. They can provide high-quality solutions for medical institutions and third-party clinical laboratories, supporting accurate clinical molecular testing.